key: cord-0961310-6449319k
authors: Zhang, Yonghui; Lin, Xiaojing; Zhang, Fengwei; Wu, Jia; Tan, Wenjie; Bi, Shengli; Zhou, Jianfang; Shu, Yuelong; Wang, Yue
title: Hemagglutinin and neuraminidase matching patterns of two influenza A virus strains related to the 1918 and 2009 global pandemics
date: 2009-09-18
journal: Biochem Biophys Res Commun
DOI: 10.1016/j.bbrc.2009.07.040
sha: bc8b2d73f71e65384dbd4056071f618a9cae7097
doc_id: 961310
cord_uid: 6449319k

The current pandemic influenza A (H1N1) virus has revealed a complicated reassortment of various influenza A viruses. The biological study of these viruses, especially of the viral envelope proteins hemagglutinin (HA) and neuraminidase (NA), is urgently needed for the control and prevention of H1N1 viruses. We have generated H1N1-2009 and H1N1-1918 pseudotyped particles (pp) with high infectivity. Combinations of HA1918 + NA2009 and HA2009 + NA1918 also formed infectious H1N1pps, among which the HA2009 + NA1918 combination resulted in the most highly infectious pp. Our study demonstrated that some reassortments of H1N1 viruses may hold the potential to produce higher infectivity than do their ancestors.

Influenza A virus, which belongs in the family Orthomyxoviridae, regularly causes epidemics, with sudden attacks in humans and animals, including the H2N2 Asian influenza of 1957 with more than 1 million deaths and the H3N2 Hong Kong influenza of 1968 with 0.5 million deaths [1] [2] [3] . Influenza A virus possesses eight negative single-stranded RNA segments that encode eleven proteins (HA, NA, NP, M1, M2, NS1, NEP, PA, PB1, PB1-F2, PB2) and is subtyped by 16 HA and nine NA envelope proteins [1] . A novel influenza A (H1N1) virus first isolated in North America has been a major global focus since April 2009, spreading to 74 countries, infecting more than 35,000 people, and causing 163 related deaths to date [4] . Genetic study has suggested that this new H1N1 virus contains a unique combination of gene segments from both North American and Eurasian swine lineages, of which PB2, PA, PB1, HA, NP, and NS are derived from North American swine lineage (triple reassortant), and the NA and M are derived from Eurasian swine lineage [5] . Simply put, this new H1N1 virus exhibits an obviously complicated gene segment reassortment of previous prevalent virus strains [6] [7] [8] [9] .

The trend of this H1N1 virus pandemic raises the memory of another H1N1 virus strain in human history, namely, the catastrophic ''Spanish" influenza virus of 1918 that killed more than 50 million people worldwide [1, 10] . Although this virus finally disappeared from detection, it is possible that this strain still remains in the earth, and any possible reassortment of two or more catastrophic H1N1 viruses may be a great challenge to human survival [9] . Although varieties of influenza A virus display a strong ability for reassortment of their gene segments [5, 11] , it is not clear whether the reassortment between H1N1 2009 and H1N1 1918 viruses will occur. Meanwhile, investigation of the biological aspects of these strains is urgently needed for influenza A virus control and prevention. In this study, we established H1N1-2009pp and H1N1-1918pp using the HAs and NAs cloned from the H1N1 viruses of 2009 and 1918. We then characterized the HA and NA matching patterns of these two influenza A virus strains to provide important biological information about these H1N1 viruses.

Cell culture. Human lung carcinoma cells (A549) and human embryonic kidney cells (293T) (American Type Culture Collection, Manassas, VA) were grown in Dulbecco's modified essential medium (DMEM, Invitrogen, CA) supplemented with 10% fetal bovine serum.

Plasmid construction. H1N1pp production. H1N1-1918pp and H1N1-2009pp were produced by transfecting 293T cells with four plasmids: the HA expression plasmid; NA expression plasmid; Gag-pol encoding plasmid; and reporter plasmid. At 72 h post-transfection, H1N1pp was harvested from the supernatant of the transfected cells by filtration through a 45-lm Durapore PVDF membrane filter (Millipore, Ireland) and used for further assays.

Infection assay. The pp infection assay was performed as reported previously [12, 13] . The naive H1N1 virus HA0 needs to be matured by TPCK-trypsin cleavage to form its functional subunits HA1 and HA2 [14] ; hence, to explore the best conditions for pp infection, pps were pre-treated with TPCK-trypsin at a final concentration of 0, 2, 40, 80,160, and 400 lg/ml at 37°C for 1 h before infection. A549 cells (5-10 Â 10 3 ) were seeded in a 96-well plate one day prior to infection. The pps were diluted 1:1 in a total volume of 100 ll DMEM. For the infection process, culture medium in the 96-well plate was replaced with the diluted pps, incubated for 4 h, and then replaced with DMEM supplemented with 3% FBS. At 72 h post-infection, the infected cells were rinsed twice with phosphate-buffered saline (PBS), and GFP reporter positive cells were counted by FACS (BD, FACSAria Franklin lakes NJ).

Hemagglutination assay. To determine the hemagglutination activity of the pps, a hemagglutination assay was performed. The pp samples were diluted serially in PBS (by 2-fold from 1 to 1/16) in 96-well plates with 50 ll per well. Then, 50-ll aliquots of 1% chicken red blood cells were added to each well and left to stand for 30 min, and the hemagglutination reaction was observed.

Data analysis. Significant differences were evaluated using a two-tailed Fisher's exact test (release 12.1; SPSS Inc., Chicago, IL). Differences were considered significant at p < 0.05.

To standardize the research, amino acid sequences of the HA from A/South Carolina/1/1918 (GenBank Accession No. AF117241) and A/California/05/2009 (GenBank Accession No. FJ966952) strains and the NA from A/Brevig_Mission/1/1918 (Gen-Bank Accession No. AF250356) and A/Ohio/07/2009 (GenBank Accession No. FJ969534) strains were aligned using the HA and NA from 1918 as the standards. Amino acids identical to the 1918 strain were replaced by ''.". The amino acid marked in red represents the cleavage site of the HA precursor linking the functional HA1 and HA2 domains (Fig. 1) , which is an arginine at amino acid position 344 [15] . Of the 569 amino acids in HA, HA2009 presents 79 (13.88%) amino acids different from those of the 1918 strain. Of the 469 amino acids in NA, 59 (12.85%) amino acids of NA2009 are different from those of the 1918 strain.

To establish functional H1N1-2009pp, plasmids for HA2009, NA2009, gag-pol, and GFP reporter were co-transfected into 293T cells, and pp were harvested at 72 h post-transfection. Prior to the infection assay, pp samples were treated with TPCK-trypsin at concentrations of 0, 2, 40, 80, 160, and 400 lg/ml. As shown in Fig. 2A, H1N1-2009pp could not infect A549 cells when pp samples were treated with 0 or 2 lg/ml TPCK-trypsin ( Fig. 2A) . Interest- ingly, H1N1-2009pp could infect as many as 8.2 ± 2.7% of A549 cells when pp samples were treated with TPCK-trypsin at concentrations of 40 lg/ml or higher ( Fig. 2A) . Similarly, as shown in Fig. 2B , H1N1-1918pp could infect as many as 7.0 ± 2.1% of A549 cells when pp samples were treated with TPCK-trypsin at concentrations of 40 lg/ml or higher (Fig. 2B) . Our data suggest that the maturation of the 2009 H1N1 virus HA precursor is similar to that of the 1918 H1N1 virus [14, 15] . Taken together, we successfully established pps representing influenza A (H1N1) virus related to both the 1918 and 2009 pandemics.

Compared to the hepatitis C virus, in which envelope proteins E1 and E2 form a functional heterodimer for virus entry [12, 13] , the influenza A (H1N1) virus also holds two envelope proteins, but their distribution seems discrete on the viral surface, with a ratio of around 4:1 [1] . To investigate whether the HA of the 2009 H1N1 virus strain matches with NA in addition to its own spousal NA of the 2009 H1N1 virus strain, we generated pps with the combination of HA2009 + NA2009, as well as the combination of HA2009 + NA1918. As described above, the combination of HA2009 + NA2009 may form infectious H1N1-2009pp well; interestingly, the chimeric combination of HA2009 + NA1918 may also form infectious pp with infectivity of 11.2 ± 3.12% (Fig. 3A) , suggesting that HA of 2009 H1N1 virus strain could match NA of 1918 H1N1 virus strain as well. Similarly, to examine whether the NA of the 2009 H1N1 virus strain matches with HA in addition to its own spousal HA of 2009 H1N1 virus strain, we generated pps with the combination of HA2009 + NA2009, as well as the combination of NA2009 + HA1918; the chimeric combination of NA2009 + HA1918 may also form infectious pp with infectivity of 9.0 ± 2.0% (Fig. 3A) , suggesting that NA of the 2009 H1N1 virus strain could match HA of 1918 H1N1 virus strain as well. Moreover, the infectivity of the NA2009 + HA1918 combination was significantly higher than both naïve combinations (p < 0.05), indicating that the NA2009 + HA1918 combination may produce a more infectious new pp (Fig. 3A) . Taken together, our data reveal that the HAs and NAs of 1918 and 2009 H1N1 virus strains may form infectious chimeric pps, raising the alarm for the possible reassortment of the two catastrophic H1N1 virus strains.

To further confirm the HA function of the H1N1pps, pp samples generated from the four combinations HA2009 + NA2009, HA1918 + NA1918, HA2009 + NA1918, and HA1918 + NA2009 were subjected to the hemagglutination assay. The hemagglutination ability of HA1918 + NA1918 was 8-fold weaker than that of the other three H1N1pp combinations, all of which were positive at a dilution of 1/16 (Fig. 3B) . These results are consistent with the infectious ability observed for the H1N1pp of HA1918 + NA1918 that displayed relatively weak infectivity to A549 cells.

In this study, we successfully generated two pseudotyped particles, H1N1-2009pp and H1N1-1918pp. Similar to all pps we have made, including hepatitis C virus [12, 13] , vesicular stomatitis virus, severe acute respiratory syndrome coronavirus, and Rabies virus (Wang, unpublished data), the H1N1-2009pp and H1N1-1918pp hold similar biological characteristics with their ancestor viruses. Our work will not only benefit the knowledge on influenza A viruses, but it also will advance the exploration of neutralizing antibodies to H1N1 virus.

One important task for influenza A virus control and prevention is to survey the possible reassortment of two or more catastrophic viruses [9] . Methods based on bioinformatics cannot provide direct solid data to support its analysis, and owing to biosafety limits, it is not suitable to perform reassortments using wild-type viruses. Consequently, our pp system provides a safe and convenient approach to investigating possible reassortments. Our data demonstrated that the combination of HA2009 + NA1918 resulted in infectivity greater than that of the naïve combinations HA2009 + NA2009 and HA1918 + NA1918. This suggests that the H1N1-2009 virus may not only recombine with H1N1-1918, but it may also produce a more infectious new virus, raising an alarm for the possible reassortment of the two catastrophic H1N1 virus strains.

Our data revealed that the infectivity of the H1N1pps depends on a certain concentration of TPCK-trypsin, suggesting that the HA precursor is matured by trypsin digestion. Our coworker's data demonstrated that the infectivity of the wild-type H1N1-2009 virus also depended on trypsin, but the concentration was only 2 lg/ml (Zhou, unpublished data). This difference might be explained by the fact that the pps in our study were harvested in DMEM supplemented with as much as 10% fetal bovine serum.

Due to the lack of serum from a recovered H1N1 infected patient, we have not performed neutralizing antibody experiments for this report; the confirmation and exploration of neutralizing antibodies are scheduled in our following research. In conclusion, we have developed a solid H1N1pp platform for studying this virus, including its receptors, the functional analysis of HA and NA, neutralizing antibodies, anti-H1N1 drug development, diagnosis of H1N1 virus, and vaccine design. 

Field Virology

Human infection with highly pathogenic H5N1 influenza virus

Influenza: lessons from past pandemics, warnings from current incidents

World Health Organization. Influenza A (H1N1)-update 49

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic

Triple-reassortant swine influenza A (H1) in humans in the United States

Cluster analysis of the origins of the new influenza A(H1N1) virus

Preparation for a pandemic: influenza A H1N1

Enhanced virulence of influenza A viruses with the hemagglutinin of the 1918 pandemic virus

Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

HCV envelope protein function is dependent on the peptides preceding the glycoproteins

Hepatitis C virus envelope glycoproteins complementation patterns and the role of the ecto-and transmembrane domains

Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter

Origin, evolution of the ''Spanish'' influenza virus hemagglutinin gene